Lasa Supergenerics Limited has informed the Exchange regarding Board meeting held on February 13, 2026.
LASA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Lasa Supergenerics reported its Q3 FY26 (quarter ended December 31, 2025) results, showing revenue from operations of just Rs 219.93 lakhs, a sharp ~93% drop from Rs 3,307.99 lakhs in the same quarter last year. The company posted a net loss of Rs 255.47 lakhs for the quarter, widening the nine-month loss to Rs 2,992.59 lakhs (EPS of negative Rs 5.97). The biggest drag was a one-time exceptional loss of Rs 824.53 lakhs in Q3 and Rs 2,057.47 lakhs cumulatively, related to a fire at its Mother Unit at Lote Parshuram, Ratnagiri in May 2025, which was uninsured and halted all production. The statutory auditor's limited review flagged concerns about going concern, dormant bank/FD balances, and force majeure treatment of customer advances.
Very negative for shareholders. Operations remain completely suspended since the May 2025 fire, the company has acknowledged going concern doubts, and there is no clear timeline for restarting manufacturing. The stock is likely to see downward pressure given collapsing revenues, mounting losses, and the absence of insurance coverage for the major asset loss.